• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

AACE President Sethu Reddy, MD, Highlights Updated 2022 Diabetes Guidelines for Primary Care

Video

The American Association of Clinical Endocrinology (AACE) in October updated its clinical guideline for developing a diabetes mellitus comprehensive care plan, a task that ultimately incorporated 170 revised and new evidence-based clinical practice recommendations based on research published since 2015, the date of the last guidline publication.

Patient Care® spoke recently with AACE president Sethu Reddy, MD, MBA, and asked him what he thinks are areas of the update most relevant to primary care clinicians who provide more than 90% of the clincal care for persons with type 2 diabetes.

In this conversation, he highlights specifics from the first section of the guideline in which authors focused on the latest evidence-based recommendations for type 2 diabetes screening, diagnosis, glycemic targets, and glycemic monitoring.

For more conversations with Dr Reddy:

Management of Type 2 Diabetes Complications, Comorbidities Focus of AACE 2022 Guideline Update


S Sethu K Reddy, MD, MBA, is the president of the American Association of Clinical Endocrinology and senior assocate dean of clinical research at Central Michigan University (CMU) College of Medicine, in Mount Pleasant, MI. Before joining CMU Reddy worked with the Cleveland Clinic in their endocrinology, diabetes and metabolism department for nearly 30 years.


Related Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
© 2024 MJH Life Sciences

All rights reserved.